A Bioinformatics Investigation into the Pharmacological Mechanisms of Sodium-Glucose Co-transporter 2 Inhibitors in Diabetes Mellitus and Heart Failure Based on Network Pharmacology

PURPOSE: Diabetes mellitus (DM) is a major risk factor for the development of heart failure (HF). Sodium-glucose co-transporter 2 (SGLT2) inhibitors have demonstrated consistent benefits in the reduction of hospitalization for HF in patients with DM. However, the pharmacological mechanism is not cle...

Descripción completa

Detalles Bibliográficos
Autores principales: Mai, Ziling, Li, Huanqiang, Chen, Guanzhong, Chen, Enzhao, Liu, Liwei, Lun, Zhubin, Lai, Wenguang, Zhou, Chunyun, Yu, Sijia, Liu, Jin, Chen, Shiqun, Chen, Jiyan, Liu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270285/
https://www.ncbi.nlm.nih.gov/pubmed/34028657
http://dx.doi.org/10.1007/s10557-021-07186-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270285/
https://www.ncbi.nlm.nih.gov/pubmed/34028657
http://dx.doi.org/10.1007/s10557-021-07186-y

Ejemplares similares